Higher TP53BP2 expression is associated with HBsAg loss in peginterferon-α-treated patients with chronic hepatitis B
Guiwen Guan(Peking University), Xiangmei Chen(Peking University), Zhenzhen Zeng(First Affiliated Hospital of Zhengzhou University), Zhiliang Gao(Sun Yat-sen University), Guochao Wei(Peking University), Jing Ning(Peking University), Sujun Zheng(Beijing Tian Tan Hospital), Changyu Tao(Peking University), Ence Yang(Peking University), Fengmin Lu(Peking University), Jing Zhang(Zhejiang Chinese Medical University), Huili Guo(Sun Yat-sen University), Jing Yang(First Affiliated Hospital of Xi'an Jiaotong University), Ren Liu(BGI Group (China)), Weilin Gu(Peking University), Na Gao(Capital Medical University), Shan Ren(Capital Medical University), Chia-Chen Chen(Peking University), Ting Zhang(Peking University), Xinyue Chen(Capital Medical University), Lin Wang(Nanjing Medical University), Xiaosen Guo(BGI Group (China))
Cited by 27
Related Papers
A global reference for human genetic variation
|Nature|2015|19.9k
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
|Journal of Hematology & Oncology|2022|178
TRIM38 inhibits TNFα- and IL-1β–triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3
|Proceedings of the National Academy of Sciences|2014|151
SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma
|Epigenetics|2010|131